These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 709512)

  • 21. Prognostic significance of CEA in colorectal cancer: a statistical study.
    Persijn JP; Hart AA
    J Clin Chem Clin Biochem; 1981 Nov; 19(11):1117-23. PubMed ID: 7310333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
    Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
    Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
    Boey J; Cheung HC; Lai CK; Wong J
    World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of carcinoembryonic antigen in the clinical management of colorectal cancer.
    Green JB; Trowbridge AA
    Surg Clin North Am; 1979 Oct; 59(5):831-9. PubMed ID: 390742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
    Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
    [No Abstract]   [Full Text] [Related]  

  • 28. Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer.
    Sugarbaker PH
    Ann Surg; 1976 Dec; 184(6):752-7. PubMed ID: 999351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of carcinoembryonic antigen (CEA) in colorectal cancer.
    Booth SN; Dykes PW; Oates GD
    Compr Ther; 1975 Aug; 1(4):49-56. PubMed ID: 1220914
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early judgement on the results in radiation therapy of colorectal cancer: determination of carcinoembryonic antigen (CEA) in blood serum at daily intervals from the beginning of irradiation (author's transl)].
    Pompecki R; Schleusner V; Ziegler HW; Winkler R; Rehpenning W
    Strahlentherapie; 1981 Feb; 157(2):81-5. PubMed ID: 7222135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Leukocyte migration test and determination of carcinoembryonic antigens in the postoperative follow-up care of colon and rectum carcinoma].
    Schulz U; Zoeller M; Matzku S
    Chir Forum Exp Klin Forsch; 1978; (1978):221-5. PubMed ID: 752590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness and limitations of CEA assay in the management of colorectal cancer.
    Tomoda H; Furusawa M
    Jpn J Surg; 1981 Jan; 11(1):33-8. PubMed ID: 7311186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
    Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
    Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinoembryonic antigen in management of colorectal carcinoma.
    Booth SN; Jamieson GC; King JP; Leonard J; Oates GD; Dykes PW
    Br Med J; 1974 Oct; 4(5938):183-7. PubMed ID: 4421372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of tumor markers in the management of colorectal cancer.
    Go VL; Zamcheck N
    Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of carcinoembryonic antigen in patients with colorectal carcinoma.
    Savrin RA; Cooperman M; Martin EW
    Dis Colon Rectum; 1979; 22(4):211-5. PubMed ID: 467173
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen: 3 years' experience in a cancer clinic.
    Koch M; McPherson TA; Morrish DW
    Can Med Assoc J; 1977 Apr; 116(7):769-71. PubMed ID: 849560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer.
    Steele L; Cooper EH; Mackay AM; Losowsky MS; Goligher JC
    Br J Cancer; 1974 Oct; 30(4):319-24. PubMed ID: 4155643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.